← back to search

Mark S. Riddle

University of Nevada, Reno · US
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Viral gastroenteritis research and epidemiology, Travel-related health issues, Escherichia coli research studies, and Hepatitis Viruses Studies and Epidemiology.
h-index
56
citations
12,862
works
350
NIH funding
primary concept
Medicine
email

Recent publications

Retrospective analysis of emerging health threats by shoreland Travax®, 2019-2024.
2026cited by 0position: contributordoi
Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data.
2024cited by 1position: contributordoi
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Gastroenterology 2023cited by 86position: middledoi
Vaccine value profile for norovirus
Vaccine 2023cited by 29position: lastdoi
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening
Vaccine 2023cited by 16position: firstdoi
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.
2023cited by 12position: contributordoi
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.
2023cited by 4position: contributordoi
Use of a Smartphone-Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Type 2 Diabetes Among Veterans: Prospective Case-Crossover Study.
2023cited by 3position: contributordoi
Advances on the forefront of travellers' diarrhoea.
2023cited by 2position: contributordoi
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease
Gastroenterology 2022cited by 61position: middledoi
Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT
Epidemiology and Infection 2022cited by 36position: middledoi
Inflammatory Bowel Disease Is Associated With Prediagnostic Perturbances in Metabolic Pathways
Gastroenterology 2022cited by 35position: middledoi
Use of a Smartphone-Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Type 2 Diabetes Among Veterans: Prospective Case-Crossover Study (Preprint)
2022cited by 0position: contributordoi
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens
Vaccine 2021cited by 29position: middledoi
Enteric Pathogens and Reactive Arthritis: Systematic Review and Meta-Analyses of Pathogen-Associated Reactive Arthritis
Foodborne Pathogens and Disease 2021cited by 20position: middledoi
Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection
Vaccine 2021cited by 19position: middledoi
Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection.
2021cited by 15position: contributordoi
Fecal Microbiota Functional Gene Effects Related to Single-Dose Antibiotic Treatment of Travelers' Diarrhea.
2021cited by 4position: contributordoi
Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018
Vaccine 2020cited by 25position: middledoi
Cholera in travellers: a systematic review
Journal of Travel Medicine 2019cited by 46position: middledoi
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years
JAMA Pediatrics 2018cited by 862position: middledoi
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
The Lancet Infectious Diseases 2018cited by 713position: middledoi
Human challenge trials in vaccine development, Rockville, MD, USA, September 28–30, 2017
Biologicals 2018cited by 50position: middledoi
Shigellosis
The Lancet 2017cited by 567position: middledoi
Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report
Journal of Travel Medicine 2017cited by 265position: firstdoi
ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults
The American Journal of Gastroenterology 2016cited by 423position: firstdoi
Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome
Journal of Travel Medicine 2015cited by 43position: middledoi
Post‐Infectious Sequelae of Travelers' Diarrhea
Journal of Travel Medicine 2013cited by 86position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2021–2026)Mark Jit · London School of Hygiene & Tropical Medicine6 papers (2020–2023)Claudio F. Lanata · Instituto de Investigación Nutricional5 papers (2020–2023)James A Platts-Mills · Virginia International University4 papers (2017–2021) · 4 papers (2020–2023)Gagandeep Kang · Tufts University4 papers (2018–2021)Mateusz Hasso-Agopsowicz · London School of Hygiene & Tropical Medicine3 papers (2020–2021)Robert F. Breiman · Emory University3 papers (2020–2021)Benjamin A. Lopman · Emory University3 papers (2020–2021)Virginia E. Pitzer · University of Antwerp3 papers (2020–2021)H Prudden · London School of Hygiene & Tropical Medicine3 papers (2020–2021)Beth D. Kirkpatrick · University of Virginia2 papers (2018–2018)Herbert L. DuPont · The University of Texas MD Anderson Cancer Center2 papers (2016–2017)Karen L. Kotloff · MRC Unit the Gambia2 papers (2017–2021)Patricia B. Pavlinac · Seattle University2 papers (2017–2021)Erika Austhof · University of Arizona2 papers (2021–2022)Peter G. Smith · Kenya Medical Research Institute2 papers (2020–2021) · 2 papers (2021–2022) · 2 papers (2015–2021)Robert C. Reiner · Hebrew University of Jerusalem2 papers (2018–2020)